Bajaire G., BorisPadilla Sierra, LeylaZabaleta Avendaño, Aida2026-04-092026-04-092008https://repositorio.sanmartin.edu.co/handle/123456789/415Abstract Purpose: To evaluate the functional and anatomical effect of bevacizumab in patients with macular edema secondary to nonischemic central retinal vein occlusion. Materials and Methods: Interventional case series study in 29 eyes with macula edema secondary to non-ischemic central retinal vein occlusion treated with 2.5 mg intravitreal Bevacizumab injection. Visual acuity, macular thickness measured with OCT and secondary effects were evaluated at presentation, 3 and 6 months after treatment. Results: We found a statistically significant difference on the macular thickness before and after intravitreal Bevacizumab injection. There is no significant difference on visual acuity before and after treatment. Conclusions: Intravitreal Bevacizumab seems to have significant effect on macular thickness and fewer effects on visual acuity in patients with CRVO.textesatribucionnocomercialsinderivarOclusión de la vena central de la retinaEdema macularBevacizumab intravítreoTrabajo de gradoRestringido